Eargo to Complete a 1-for-20 Reverse Stock Split
SAN JOSE, Calif., Jan. 11, 2023 (GLOBE NEWSWIRE) — Eargo, Inc. (“Eargo” or the “Company”) (Nasdaq:EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced that its Board of Directors has approved a 1-for-20 reverse stock split of the Company’s common stock. The Company’s common stock is expected to begin trading on a split-adjusted basis when the markets open on Wednesday, January 18, 2023, under the existing trading symbol “EAR” and a new CUSIP number: 270087208.
Related news for (EAR)
- Ellington Credit Company Reports Preliminary Fourth Quarter 2024 Results and Provides Conversion Update
- Turtle Beach Corporation Announces Ticker Symbol Update to “TBCH”
- Ellington Credit Company Reports Third Quarter 2024 Results
- turtle beach corporation to report third quarter 2024 financial results on thursday, november 7, 2024
- turtle beach drives growth in key international markets, including canada and key territories in latin america